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Thrombosis is a serious complication of hear waive replacement .
Diagnosis is often difficult with previously reported techniques,
including precordialtwo.dimensionnlechocarrliography,suffering
iron low sensitivity and specificity. Management is similarly
di®cult, with a 40% to 50% reported mortality rate in early
surgical series. Three cases are presented in which thrombosis of
a left-sided prosthetic valve (one aortic, three mitral) was diag-
nosed by means of transesophageal echocardiography. All three
patients were treated with streptokinase and had clinical and
echoeardiographic resolution . In one patient, who had recurrent
thrombosis and received a second course of streptokinase, the
Thrombosis is an infrequent but life-threatening complica-
tion of cardiac valve replacement . Diagnostic techniques
used until now have lacked both sensitivity and specificity
(1,2)
.
Management has invariably focused on surgical re-
moval and replacement of the thrombosed valve . However,
surgical management has been associated with high mortal-
ity rates, especially when surgery was performed in the
emergency setting (3,4). In recent years, investigators have
reported the use of thrombolytic therapy as the primary
technique in the management of this serious complication .
We describe four cases of prosthetic valve thrombosis in
three patients treated with streptokinase, in whom the diag-
nosis and effectiveness of thrombolytic therapy were deter-
mined by transesophagealechocardiography .
Methods
Baseline and follow-up tmnsesophageal echocardiog-
raphy were performed in all three patients with use of a
Hewlett-Packard echocardiographic system t77020CF1 with
a 5-MHz single-plane short-axis transesophageal probe
.
Consent for thrombolytic therapy was obtained from each
patient . In all cases, thrombolytic therapy was initiated
within 24 h of the baseline echocardiographic studies . Strep-
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course was complicated by a massive embonc stroke and death .
Another patient with a recurrence underwent successful valve
replacement.
Trausesophageat echocardiography is idea for the diagnosis
and follow-up of patients with prosthetic valve thrombosis . Al-
though effective, thrombotysis in this setting is associated with a
high risk of thromboembolic phenomena and significant risk of
death. Thrombolytietherapy may be considered in highly selected
patients who have an unareepmbte risk for reoperetion .
(1 Am Coll Cardiol 1991;18 :1829-33)
tokinase therapy was started with an intravenous bolus
injection of 500,000 to 750.000 U over 30 min (1,2) followed
by infusion at a rate of 100.000 to 300,000 Ulh for a period of
48 to 96 h. Adjustments were made in the infusion rate to
achieve a thrombolytic state (serum fibrinogen level <0
.2
glliter) . Repeat transesophageal echocardiographic examina-
tions were performed within 48 h of thrombolytic therapy .
The streptokinase infusion was followed by intravenous
infusion of heparin, which was given for up to 7 days
. The
partial thromhoplastin time was maintained at 2 times the
control level. All patients were discharged on treatment with
warfarin (Coumadin), which was started and adjusted in the
hospital to achieve a stable prothrombin time 1 .5 limes the
control time .
Case Reports
Case I
Clinical presentation. Patient 1, a 40-year old woman
with a known bicuspid aortic valve 19 years after removal of
a left ventricular myxoma, presented with left hemiparesis
and was found on echocardiography to have severe aortic
steoosis and moderate aortic regurgitation . She underwent
aortic valve replacement with a size 20 Medtronic-Hall valve
and was discharged home on treatment with digoxin, war-
farin and dipyridamole. Four months after herinitial hospital
stay, she was admitted with a 5-week history of tight calf
pain, headaches, vertigo, blurred vision and generalized
numbness
. Anticoagulation was suboptimal, On examina-
tion, the heart rate was 88 beats,min and blood pressure
0735-Ia97N1153.50
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Figure 1. Patient I . Short-axis transesophageal echocardiographic
scan of the mechanical aortic valve demonstrated a large mobile
mass (arrow) before thrombolytic therapy (A) and its complete
resolution after therapy (0). AV = aortic valve : LA = left atrium ;
Th = thrombus .
160/85 mm Hg . She was afebrile. Auscultation revealed a
loud and discrete second heart sound and a grade 3/6 ejection
systolic murmur at the !oft sternal border.
Echocardiographie findings (Fig . 1). Because of the echo-
genicity of the prosthetic valve struts, precordial echocar-
diography did not provide adequate visualization of the
aortic valve . There was no suggestin- of a mass . Trans-
esophageal echocardiography revealed a mobile mass at-
tached to the anterior aspect of the suture ring within the left
ventricular outflow tract (Fig . IA) . Disk excursion appeared
normal . The peak aortic gradient measured by transthoracic
Doppler echocardiography was 40 mm Hg .
Treatment . Because the previous valve replacement had
been technically difficult, the surgical team considered this
patient to be at high risk for another operation . She was
referred for thrombolytic therapy and received 750 .000 t1 of
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streptokinase over 30 min followed by an infusion at
100,000 U
. The infusion was discontinued at 34 h because of
onset of a rash, back pain and numbness . Serial serum
fibrinogen levels during streptokinase infusion were
<0.2 gilder. Results of a neurologic examination were nor-
mal
. Anticoagulant therapy was initiated according to our
protocol . Repeat transesophageal echocardiographic exami-
nation 2 days after thrombolytic therapy was initiated
showed no evidence of the previously seen mass (Fig. IB).
The peak aortic valve gradient was 23 mm Hg. She contin-
ued to do well on clinical and echocardiographic follow-up at
22 months.
Case 2
Clinical presentation . Patient 2 was a 51-year old woman
who 7 years earlier had undergone replacement of a stenotic
mitral valve with a Medtronic-Hall prosthesis . She was well
until gradual onset of congestive heart failure of a few
weeks' duration, which resulted in transfer from a peripheral
hospital for assessment and management . Examination re-
vealed a heart rate of 80 beats/min
; blood pressure was
100170 an Hg . There was a grade 2/6 long diastolic rumble .
The previously noted opening click was absent
. Cardiac
catheterization revealed a mean mitral valve gradient of
11 mm Hg
.
Echocardiographic findings (Fig. 2). Because of concern
regarding possible thrombosis, echocardiography was per-
formed. The precordial examination demonstratec de-
creased poppet motion; no masses were seen . The trans-
esophageal echocardiographic study demonstrated an echo
density consistent with a thrombus attached to the ventric-
ular surface of the poppet laterally (Fig
. 2A). The excursion
of the poppet was restricted to 20' (normal excursion for this
type of a valve is about 70°) . Fractional shortening of the left
ventricle was 22% . The pressure half-time was prolonged at
206 ms and the mean gradient across the mitral valve was
8 mm Hg.
Treatment. Because of the compromise in ventricular
function, the surgical team considered this patient to be at
high risk for emergency valve replacement . Thrombolytic
therapy with 500.000 U of streptokinase over 30 min was
followed by a continuous infusion of 100,000 U/h and an-
other bolus dose of 750,000 U . The serum fibrinogen level
after the second bolus dose was <0 .2 g/liter . The therapy
was complicated by sudden transient pain in the left side of
the chest and loss cf right brachial and radial pulses . Two
days after thrombolytic therapy, repeat transesophageal
echocardiographic examination showed resolution of the
mobile mass and normal mitral valve disk excursion (Fig .
2B) . The pressure half-time was 90 ms and the mean gradient
was reduced to 4.8 mm Hg. Anticoagulant therapy was
resumed .
Clinical course . The patient was well until 14 months
later when she again noted increasing dyspnea with exertion .
Prothrombin lime was subtherapeutic . Transesophageal
fACC Vol . 1e. No. 1
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Figure 2 . Patient 2
. Long-ax's tmnsesophageal scan of the mechan-
ical mitral valve (htV5 shared a large thrombus an the poppet,
restricting its excursion (A). After thromholytic
therapy.
there was
normal poppet excursion and the thrombus (Th) was smaller (8).
Subsequent tmnsesophageal examination showed complete resole
-
lion of the thrombus . Abbreviations as in Figure I .
echocardiography demonstrated recurrence of the homoge-
neous echo-dense material on the mitral valve, covering the
entire suture ring and extending into the left ventricular
inflow tract. The mass was similar in appearance but more
extensive than that during her initial presentation
. She was
admitted for another course of thrombolytic therapy with a
500 .000-U bolus dose of streptokinase followed by an infu-
sion of 100,000 U/h . The serum fibrinogen level was
<0 .2 g/liter . Twelve hours after the start of infusion, a dense
right hemiparesis developed. followed by coma and death .
Autopsy revealed an embolic stroke with normal cerebral
DbsVIK ET AL.
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circulation . The prosthetic mitral valve was packed with
dense thrombotic material .
Case 3
Clinical presentation . Patient 3, a 46-year old woman
with a history of rheumatic fever in childhood . had had a
closed mitral commissuretomy at age 32 years and subse-
quent mitral valve replacement with a size 40 Medironic-
Hall valve at age 44 years . after which she was placed on a
regimen of warfarin and dipyridamole . She was then well
until a few months before admission . when she began to
experience episodes of diplopia and blurred vision and was
admitted to the hospital after undergoing two transient
isodes of aphasia and hemiparesis . Precordial echocar-
diography showed a normally functioning prosthetic valve ;
there was no suggestion of a mass or vegetation. Because her
symptoms persisted
. she was admitted to our center for
further management . Examination showed normal valve
sounds with no evidence of heart failure,
Echocaediographte findings (Fig
. 3)
. Precardial two
.
dimensional echocardiography was nondiagnostic . How-
ever. tmnsesophageal echocardiography revealed multiple .
mobile, strandlike echo densities, believed to he thrombotic
material attached to the atria) side of the poppet of the well
seated prosthesis ; there was a mild degree of spontaneous
contrast within the left atrial cavity (Fig
. 3A)
. There was no
evidence of valvular obstruction .
Treatment
. The patient was reluctant to undergo surgical
valve replacement. However, she agreed to a trial of throm-
bolytic therapy with streptokinase . After an intravenous
bolus injection of 500.000 U, she was maintained on an
infusion of 0_300,000 Ulh for 4 days . Adequate thrombolylic
state was not achieved because, except for one value of
<0 .2 glliter, the serum fibrinogen level remained between
0 .75 and 2 .8 Oiler . After the trial of thrombolysis, the
patient's anticoagulant therapy was resumed . Repeat trans-
esophageal echocardiographic studies showed improvement
but incomplete resolution of the mobile mass (Fig . 3B)
. The
strandlike densities were similar in appearance to those seen
in the initial study but were decreased in number
.
Clinical course. After 2 years without complications . the
patient had two episodes of right arm weakness and dyspha-
sia
. Multiple strandlike echo densities similar to those seen
on her first presentation, were again noted on the trans-
esophageal echoeardiographic examination
. She finally
agreed to surgical treatment, during which she was found to
have thrombus material around the suture ring . The valve
was replaced and she has been well since .
Discussion
Prosthetic valve thrombosis continues to be a significant
source of morbidity and mort dity . complicating up to 3%
and 13% of Bjork-Shiley valve replacements in the aortic and
mitral positions, respectively. a t 4 years (5). The mortality
183/
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Figure 3 . Patient 3 . Long-axis transesophageal scan of the mechan-
ical mitral valve showed multiple strandlike densities at the suture
ring (A).
There was a decrease in these mobile echo densities after
thrombolytic lher:.py (B). Abbreviations as in Figure 2 .
rate in early -eries (3,4) was reported to be about 40% to 50%
despite emergency surgical intervention .
IACC Vul . Ia. No. 7
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Results of thrombolytic therapy . The first successful case
of thrombolysis of a Starr-Edwards tricuspid valve thrombus
was repoaed in 1971 (6) . Five other cases of thrombosis of a
prosthetic tricuspid valve, all treated successfully and with-
out complications, have been described (7-9). Thrombolysis
of left-sided prosthetic valve thrombosis in 12 patients was
described
in 1980 (1) and a total of 45 patients thus treated
have been reported (1,2,10-12) (Table 1) . The overall suc-
h ss late is 81 .6% and the embolic rate is 18 .4% .
Our experience and that previously reported suggest that,
in the appropriate setting, thrombolysis may be the therapy
of choice in prosthetic valve thrombosis, with the majority of
clots undergoing successful lysis with standard thrombolytic
protocols
. However, patients must be selected with careful
consideration given to the risk and benefit of surgery or
thrombolysis in each case . The poor outcome related to a
massive embolic stroke in Patient 2 illustrates one of the
catastrophic risks and pitfalls of thrombolysis of left-sided
prosthetic valve thrombosis. The overall mortality rate as-
sociated with thrombolytic therapy directly attributable to
thromboembolism is 11 .1% for all reported studies com-
bined .
Surgical results. Surgical risk has been !inked to preoper-
ative New York Heart Association functional class, left
ventricular contraction grade, age, urgency of operation and
concomitant coronary artery disease (13-16) . In high risk
cases, the operative mortality rate is as high as 30.4% for
aortic valve replacement and 45 .5% for mitral valve replace-
ment (16) .
In aortic valve replacement, prior cardiac surgery
itself has been associated with an operative mortality rate of
10% to 30.4% (15,16).
Indications for thrombolytie therapy . Thrombolytic ther-
apy should be reserved for those patients with prosthetic
valve thrombosis who are found to be in functional class IV
or have poor left ventricular function, those who require
emergency intervention, the elderly or patients with signifi-
cant noncardiac risk factors for surgery
. Two of our patients
were considered to be at high risk for surgery and one
refused surgery . Thrombolylic therapy with intravenous
streptokinase was administered to these patients no this
basis .
Ta,lle 1. Combined Data From 45 Reported Patients With Left-Sided Prosthetic Valve Thrombosis Undergoing T u,ombolytic Therapy
aortic ; Ham - hemorrhagiq M = mitral ; Sung =
surgical,
Thromb = thromboic and thramboembolic.
No. of Patientsl Valve Clinical
Complications Death
Amlmrs(referenee) Cases Location Success Embolic Hem Sara Total Surg Thromb
V2dchilz et al
. 11) 12113 tM/4A 9113 0 5 3 1
' .II- J . (10) 111 I/M III 0
a 0 0 o 0
Ragliu el a] . (Ill III :M 011 0 I 0 1 0 1
Lori- Rouaaa et al. (2) 2028 UMII IA 25128 5 0 4 4 2
Kurarok et aI. (9)
Ill IM III 0 a o 0
Mxrciskoviate el al. (12) Ill IM III 0 0
0
0
Pnsnel study 314 2M/IA 314 2 0 0 1 n 1
"local 45149 29M116A 40/49 9 3 9 9 4 5
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Diagnostic problems. Previously used methods to diag-
nose and follow up prosthetic valve thrombosis have sit-
fered from lack of sensitivity and specificity (I,21 . Although
precordialtwo-dimensionalechocardiography has boon used
in recent years, there are no reported studies showing the
sensitivity or specificity of this technique in the diagnosis of
prosthetic valve thrombosis . The use of Doppler ultrasound
was described recently (17)- but this technique also suffers
front lack of specificity . It is difficult if not impossible :a
demonstrate thrombus in the case of a mechanical prosthesis
because of
the echogenicity of the poppet. struts and suture
ring. Reverberation of these structures leads to masking of
neighboring structures, Other criteria . such as partial open-
ing of the valve, are nonspecific and may lead to incorrect
diagnosis and management. Accurate diagnosis is essential
in this setting, especially when consideration is being given
to intervention such as reoperation
for
valve replacement or
thrombolytic therapy
. both of
which have the potential for
significant morbidity and mortality .
Use of transesophageal echocardiography . We report to,
the first time the use of lransesophagealachocardiographyin
the diagnosis and follow-up
of
a lhrombosed prostheti^
valve . This technique offers superior resolution of a degree
that allows direct visualization of thrombus associated with
mechanical prosthetic valves . We were able to use Irans
esophageal echocardiography not only to make the initial
diagnosis, but also to document complete resolution of
thrombus in two patients and partial improvement in a third
patient who initially refused surgical therapy but agreed to
reoperation after two further embolic events .
Summary . Transesophageal echocardiography I, idea:
for the diagnosis and
follow-up of prosthetic heart valve
Thrombosis . The efficacy of thrombolytic therapy in this
clinical setting should be carefully weighed against the
significant thromboembolic risk involved .
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